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Abstract  Aim: An aortic dissection is an uncommon serious condition, which usually presents with chest pain or 
upper back pain. Symptoms of aortic dissection may mimic those of other diseases, often leading to delay in 
diagnosis. Methods: We report an unusual case of aortic dissection with hemopericardium and thrombosed left 
common iliac artery presenting as acute limb ischemia. Conclusion: Maintaining a high index of clinical suspicion 
for aortic pathology could possibly lead to identification and timely management of a greater number of patients 
who have atypical presentations. This would be especially true for patients who have catastrophic presentations with 
unexplained symptoms. 
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1. Introduction 
An aortic dissection (AD) is an uncommon serious 
condition, which is usually fatal even before arrival to 
emergency department (ED). Symptoms of AD may 
mimic those of other diseases, often leading to delay in 
diagnosis. The acute onset of severe chest pain or upper 
back pain was the most common initial complaint and less 
common manifestations include widened mediastinum on 
chest x-ray, congestive heart failure, syncope, cerebrovascular 
accident, shock, paraplegia, and lower extremity ischemia. 
2. Case Presentation 
A 43 year old African American male with past medical 
history of Hypertension (HTN), current smoker, Motor 
vehicle accident (MVA) few months ago with back trauma 
was getting physical therapy presented with sudden onset 
of lower back pain while getting into the car which 
radiated to left leg followed by numbness and weakness of 
the left leg. He had multiple episodes of vomiting 
containing clear contents before coming to ED. On arrival 
to ED, his vitals were: heart rate (HR) regular at 83 beats 
per minute, blood pressure (BP) 153/74 mm Hg, 
respiratory rate 16 cycles/min and saturation 100% on 
room air. On physical examination patient had feeble 
femoral, popliteal, dorsalis pedis pulses in right leg, and 
absent femoral, popliteal, dorsalis pedis pulses in left leg. 
Power: right leg 4/5 and 0/5 in left leg. Sensations were 
intact in right leg but there was loss of touch and pain 
sensation in the left leg below the knee. Both lower 
extremities were cold but left lower extremity was 
extremely cold. Remaining physical exam was normal. 
 
Figure 1. Computed Tomography of chest showing hemopericardium 
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Figure 2. Computed Tomography of chest showing aortic dissection 
involving aortic root 
 
Figure 3. Computed Tomography of chest showing hemopericardium 
and descending aortic dissection 
 
Figure 4. Computed Tomography of chest showing thrombosis of left 
common iliac artery 
Initial work up that included electrocardiogram, chest 
radiography and basic labs were completely normal. 
Vascular surgery was consulted to rule out acute limb 
ischemia. In next couple of hour’s patient’s BP dropped to 
78/50 with HR ranging from 114-130 beats per minute. 
Patient did not respond to fluid bolus and was started on a 
norepinephrine drip. Repeat labs showed drop in 
hemoglobin from 13.2 to 12.1 g/dl, increase in blood urea 
nitrogen/creatinine 16/1.0 to 19/2.2 mg/dl, lactic acid > 12 
mmol/L and negative troponins. After stabilizing the 
patient, CT chest, abdomen, pelvis and lower extremity 
was done which revealed large hemopericardium [Figure 1] 
with aortic dissection originating at the aortic root, 
extending into the distal thoracic aorta [Figure 2, Figure 3] 
with thrombosed left common iliac artery [Figure 4].  
Patient was evaluated by vascular and cardio-thoracic 
surgery and was transferred to other facility for emergent 
surgery. Patient underwent replacement of ascending aorta, 
hemi-arch and resuspension and repair of aortic valve with 
a 32 mm Hemashield double Velour Dacron graft. Total 
circulatory arrest time was 42 minutes and received 
antergrade cerebral perfusion for 41 min. Patient also 
underwent femoral-femoral bypass surgery. After the 
surgery, patient’s limb got better and was transferred to 
rehabilitation center. Patient continues to follow at 
cardiovascular and vascular surgery clinics and was doing 
well for the last 18 months. 
3. Discussion  
3.1. Introduction 
AD is an uncommon serious condition, which usually 
presents with chest pain and upper back pain but can have 
many atypical presentations such as stroke, myocardial 
infarction, syncope, mesenteric and limb ischemia 
[1,2,3,4]. Many patients die even before they present to 
the ED or prior to the diagnosis [5]. Our patient presented 
with low back pain and acute lower limb ischemia and 
found to have type A aortic dissection with 
hemopericardium in addition to occlusive thrombus; 
incidentally diagnosed on complete vascular imaging, 
which was done to investigate the cause of hemodynamic 
instability. Aortic dissection can present with impaired or 
absent blood flow in peripheral vessels (carotid, brachial, 
femoral) [1]. This pulse deficit most commonly results 
from intimal flap or compression by a hematoma [5]. 
Literature review showed, very few cases have been 
reported with concomitant AD and acute distal arterial 
thromboembolic occlusion of a vessel [6,7,8,9]. 
Olsson C. et al. reported an incidence of 9.1 cases per 
100,000 in women increasing to 16.3 per 100,000 in men 
based on study from national heath care registry data and 
out of hospital death autopsies [10,11] and Howard et al. 
reported incidence of 6 cases per 100,000 population in 
Oxford Vascular study [12]. AD is more frequently seen 
in men compared to females in a ratio of 1.5: 1 and men 
developed at younger age compared to females (79.3 
verses 67.1 years) per Oxford vascular study [12]. Marfan 
syndrome patients develop AD at very young age (less 
then 40 years) [5]. Diagnosis is often missed in up to 38% 
of cases on initial evaluation and first established in 28% 
of cases during autopsy [1,13]. 
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3.2. Etiology and Pathogenesis 
AD is a longitudinal tear initiated in intima progressing 
to disruption of the medial layer thus creating true and 
false lumen, which could extend the tear in either 
directions of aorta resulting in rupture of aorta, 
hemopericardium, massive blood loss, end organ ischemic 
damage as in our case and death [5,6,11]. AD is described 
as acute if symptom onset is less than 2 weeks and chronic 
if more than 2 weeks [5,11]. AD type based on anatomy is 
classified by two classification systems. Stanford system 
classifies dissections that involve the ascending aorta as 
type A and all other dissections as type B regardless of the 
site of primary intimal tear. [2,4,5,11] Where as the 
DeBakey classifies as type I involving the ascending aorta 
and the aortic arch, type II involving the ascending aorta 
only and type III involving the descending aorta only [2,5, 
11]. Chronic systemic hypertension is the most common 
predisposing risk factor implicated in AD. It is prevalent 
in 62 to 78% patients with AD [1,5,11,12,13] and 
increases the aortic wall stress initiating the tear in intima 
[5,11]. Hypertension leads to structural (atherosclerosis, 
myo-intimal thickening) and functional (increased 
stiffness, loss of endothelial function) changes in the 
arterial system and eventually leading to structural 
changes of left ventricle (hypertrophy). This interplay 
between ventricle and arterial system is called as 
ventricular-vascular coupling [14]. Initially it is an 
adaptive phenomenon and over time with chronic 
hypertension, aging and other factors lead to heightened 
arterial stiffness, change in pressure wave amplifications, 
velocity and its timing, leading to ventricular-vascular 
mismatch which acts as a main underlying 
pathophysiology for cardiovascular diseases such as 
myocardial ischemia, heart failure, aneurysms and 
dissections [14]. Understanding ventricular-vascular 
coupling helps in determining pathophysiology of 
cardiovascular manifestations [14]. Other etiologies that 
would increase the wall stress are physical trauma, 
deceleration injury in motor vehicle accidents and falls 
[15,16] pheochromocytoma and cocaine use from 
catechocholamine surge [17], and coarctation of aorta. 
Smoking also increases the risk of dissection by affecting 
Transforming growth factor TGF-B that promotes smooth 
muscle growth and function in the media [11]. Our patient 
had chronic systemic hypertension, chronic smoker and 
also experienced motor vehicle accident which would be 
predisposing factors for AD. Other predisposing factor 
contributing to AD is medial degeneration seen in 
conditions such as Marfans syndrome, Noonan syndrome, 
Ehlers-Danlos syndrome, Turner syndrome, inflammatory 
diseases of aorta and bicuspid aortic valve [7,18,19]. 
Hagan et al. reported 4.3% in IRAD study [13] Litchford 
et al. [20] and Archer AG et al. [21] reported 5% had 
direct iatrogenic AD from previous cardiac surgery during 
arterial cannulation or during catheter based diagnostic or 
therapeutic interventions. Most of the iatrogenic 
dissections result in type B dissections. 
3.3. Management  
Having high index of clinical suspicion is the foremost 
important step in diagnosing devastating disease. 
Computed tomography (CT) is most common, readily 
available and widely used modality for quick diagnosis of 
AD. It has high sensitivity (83-94%) and specificity (87-
100%) in diagnosing AD [22]. The presence of an intimal 
flap is characteristic of AD as shown in Figure 2 and 
Figure 3. Helical or spiral CT is shown to be superior 
compared to conventional CT in detecting AD. Trans-
esophageal echocardiogram is highly sensitive (97-99%) 
and specific (97-100%) in diagnosing AD, identifying the 
entry site of dissection, presence or absence of thrombus, 
involvement of coronaries and arch vessels, aortic valve 
involvement and hemodynamics across the aortic valve 
and pericardial effusion [23,24,25]. Magnetic resonance 
imaging also has very high sensitivity and specificity in 
range of 95-100%, provides all the information 
comparable to TEE and helpful in patients with previous 
aortic disease, surgical repair and in construction of three 
dimensional images [26,27]. Chest radiography, 
electrocardiogram and trans-thoracic echocardiogram are 
less specific in diagnosing AD. Chest radiography lacks 
specificity but helps in predicting the disease. Widened 
mediastinum is seen in 50% of cases with AD. Presence of 
non-specific changes on electrocardiogram in a patient 
with chest pain, diagnosis points towards AD over 
myocardial infarction. Aortography is an invasive, time 
consuming procedure and rarely used in recent days. 
Type A dissections require urgent surgical intervention 
where as Type B dissections are managed medically with 
blood pressure control and pain management [2,4,5]. 
Understanding ventricular-vascular coupling helps in 
determining pathophysiology of cardiovascular 
manifestations and its management modulation [14]. 
Unoperated type A dissections have estimated mortality 
rate of 1% per hour to 2% per hour during first 48 hours 
[28]. AD resulting in rupture has a 90% mortality rate [6]. 
Fann et al. reported overall operative mortality rate for 
acute AD is 24% ± 8%, acute type A AD it is 26% ± 3%, 
acute type B dissection 39% ± 8% [29] and 50 to 70% for 
renal ischemic patients [30]. Per IRAD study in-hospital 
mortality rate for type A dissection patients treated 
surgically was 27 % compared to medical management 
(high operative risk and elderly patient population) was 
58% and for type B dissection patients managed medically 
was 10.7 % and 31.4% in surgical group.  
Surgery is the standard of care and it is indicated in all 
type A dissections, unless serious comorbidities preclude 
surgical intervention [31]. The aim of surgery is to excise 
and replace the aortic segment with dissection but not to 
replace entire dissected aorta and to maintain aortic valve 
integrity. Best-known surgical procedures for type A 
dissections are the Bentall, David (valve sparing), Yacoub, 
Ross, aortic homograft and Elephant technique 
[5,11,19,32]. Glue aortoplasty is usually combined with 
AD surgical procedure. Our patient underwent valve 
sparing aortic root replacement surgery (David procedure). 
There is no role for endovascular stents in type A 
dissections [33]. 
Type B dissections are managed medically unless 
complicated. Medical management is shown to be superior 
to management with either surgical or endovascular stent 
approach in uncomplicated type B dissections. The 
cornerstone of medical management is tight Blood 
pressure and heart rate control with B-blockers and 
vasodilators such as Angiotensin-converting-enzyme 
inhibitors (ACEI) aiming to reduce the force of left 
ventricular contractions, to decrease steepness of the rise 
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of the aortic pulse wave (ie, dp/dt) and pain management 
[5]. Surgical or endovascular intervention is indicated in 
complicated type B dissections, which comprise of type B 
dissection with persistent or recurrent pain despite 
adequate antihypertensive therapy with at least two 
parenteral agents at moderate to high dose, aortic diameter 
≥ 5.5 cm, diameter increase > 4mm, acute expansion of 
the false lumen, periaortic or mediastinal hematoma 
(contained rupture) and in visceral, renal or limb 
malperfusion syndrome [34]. Surgical interventions 
include replacement of aorta or bypass surgery. Our 
patient underwent femoral-femoral bypass surgery, which 
resulted in complete recovery of left leg ischemia. Hybrid 
procedure includes combination vascular surgical 
procedure and endovascular stents. IRAD study showed, 
patients who underwent thoracic endovascular aortic 
replacement (TEVAR) for type B dissections had lower 5-
year mortality compared to patients treated medically 
[11,35]. Based on IRAD study data, the food and drug 
administration (FDA), Society for Vascular surgery (SAS), 
American Association for Thoracic surgery, Society of 
Thoracic Surgeons and the Society for Interventional 
Radiology recommended TEVAR for complicated type B 
dissections [11,36]. 
AD managed medically or surgically needs long-term 
care and follow up as they have potential to develop aortic 
aneurysm and propagate dissection. Long-term management 
consists of aggressive blood pressure control, smoking 
cessation and clinical and imaging assessment of the aorta 
for early detection and correction of the potential 
complications [5,37]. Tight blood pressure control may 
reduce incidence of re-dissection in about one third of 
patients [38]. IRAD database showed B-blockers are 
associated with improved survival in type A dissections 
[39]. 
Our patient presented with concomitant Stanford type A 
AD and left common iliac arterial thrombosis. It presents a 
therapeutic dilemma as the management of arterial 
thrombosis usually involves inhibition of the coagulation 
cascade. There were no clear guidelines for management 
of AD with malperfusion or arterial thrombosis and use of 
anticoagulants, but the general consensus was to treat 
aortic dissection first as it would correct malperfusion in 
most patients [40]. Thoracic aortic surgery is associated 
with hemorrhage due to numerous interrelated causes such 
extensive surgical exploration, arterial and venous 
bleeding, consumptive coagulopathy, antithrombotic use, 
platelet dysfunction, coronary bypass and hypothermia 
[40]. The Society of Thoracic Surgeons (STS) and The 
Society of Cardiovascular anesthesiologists (SCA) have 
defined clinical practical guidelines for use of blood 
products during perioperative period. However there was 
no clear time frame defined to start anticoagulation or 
venous thromboembolic prophylaxis post-operatively [41]. 
Study by Kincaid et al. showed that patients receiving low 
molecular weight heparin (LMWH) within 12 hours of 
cardiac surgery have significantly greater blood loss and 
increased blood transfusion compared with patients 
receiving intravenous heparin or a dose of LMWH more 
than 12 hours before operation [42]. Medalion et al. 
showed that the risk of postoperative bleeding or 
transfusion requirement is less if enoxaparin administered 
more than 8 hours before coronary artery bypass surgery 
[43]. For patients undergoing cardiac surgery, it is 
recommended to use mechanical prophylaxis with intermittent 
pneumatic compressions (IPC) in uncomplicated post 
operative course, low dose unfractionated heparin (LDUH) 
or LMWH in addition to IPC in patients whose hospital 
course is complicated by one or more non hemorrhagic 
surgical complications and in patients with moderate risk 
for venous thromboembolism (VTE) and not high risk for 
perioperative bleeding, LDUH or LMWH or mechanical 
prophylaxis with IPC over no prophylaxis [44].  
Unfractionated Heparin is widely used in perioperative 
period especially in cardiac surgery [40] due its shorter 
half life, less bleeding risk and availability of strong 
reversal agent, but its use is limited by concerns of heparin 
rebound, heparin resistance, protamine reaction, heparin-
induced thrombocytopenia, heparin- induced platelet 
dysfunction and less anti-thrombotic activity compared to 
LMWH. Literature review showed wide spread usage of a 
second generation LMWH - Bemiparin, in Europe in 
perioperative period including high-risk surgical 
procedure [45]. Its usage is getting wider given its better 
pharmacological profile – anti-factor Xa:anti-factor IIa 
(8:1), increase in release of tissue factor pathway inhibitor 
from endothelial cells under both static and shear stress 
conditions, more favorable efficacy: safety ratio and 
shown to be superior to fondaparinex, and unfractionated 
heparin in suppressing angiogenesis and vasculogenesis 
[45]. Bemiparin may have a potential for use in cardiac 
surgeries with malperfusion like our case in perioperative 
period but needs further studies evaluating its use. Our 
patient was severely coagulopathic after he was rewarmed 
and weaned of cardiopulmonary bypass necessitating 
multiple rounds of clotting factors. He was placed on 
venodyne boots in perioperative period and started on 
subcutaneous heparin on first post-operative day. 
4. Conclusion 
Maintaining a high index of clinical suspicion for aortic 
pathology could possibly lead to identification and timely 
management of a greater number of patients who have 
atypical presentations [1,2,4,5,13]. This would be 
especially true for patients who have catastrophic 
presentations with unexplained symptoms.  
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